Pharmaceuticals

Cancer Vaccines Market Outlook 2026–2030 Driven By Growth Factors And Projections

April 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Cancer Vaccines Market In 2026, And How Will Its Value Evolve By 2030?

The cancer vaccines market size has experienced rapid growth in recent years. It is anticipated to expand from $9.36 billion in 2025 to $10.66 billion in 2026, at a compound annual growth rate (CAGR) of 13.9%. The historical growth of this market can be attributed to increasing global cancer prevalence, the limited effectiveness of conventional cancer treatments, growing awareness of cancer immunotherapy, rising investment in oncology research, and early regulatory approvals of cancer vaccines.

The cancer vaccines market size is projected for substantial expansion over the coming years. Its valuation is expected to reach $18.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.3%. This anticipated growth is primarily driven by enhancements in vaccine platforms and delivery systems, the escalating embrace of personalized cancer vaccines, the broadening of clinical pipelines for therapeutic vaccines, increased government funding for cancer research, and the rising demand for combination cancer therapies. Significant trends for the forecast period include the increasing development of therapeutic cancer vaccines, a heightened focus on personalized and targeted immunotherapies, a surge in clinical trials for innovative cancer vaccine technologies, the expansion of preventive vaccination programs aimed at cancer prevention, and a growing number of collaborations between pharmaceutical companies and research institutes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp

Which Primary Drivers Are Impacting The Cancer Vaccines Market Growth?

Elevated government investment in research and development is projected to propel the expansion of the cancer vaccines market in the coming period. Government funding represents financial resources provided by a government for a specific objective. This financial support for research and development is increasing to foster innovation and accelerate the creation of novel technologies and treatments capable of addressing critical health and economic challenges. Cancer vaccines support government funding for research and development by opening up opportunities for investment in preventive and therapeutic innovations, thereby encouraging greater financial backing for vaccine research programs. For instance, in September 2023, the National Cancer Institute, a US-based government agency, received a budget of $7.3 billion from the United States Congress for fiscal year 2023, which constitutes a $408 million increase over 2022. Consequently, the rising government funding for research and development is driving the growth of the cancer vaccines market.

How Are Different Segments Classified In The Cancer Vaccines Market Segment Analysis?

The cancer vaccines market covered in this report is segmented –

1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines

3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types

4) By End-User: Cancer Treatment Centers, Research Institutes

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines

2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), Other Therapeutic Vaccines

What Trends Are Influencing The Evolution Of The Cancer Vaccines Market?

Leading companies within the cancer vaccines market are increasingly focusing on introducing quadrivalent vaccines to maximize revenue in the market. A quadrivalent vaccine is defined as a vaccine providing protection against four distinct strains or types of a specific virus or bacteria. For instance, in January 2023, Serum Institute of India, an India-based biotechnology company, launched CERVAVAC, which is the first made-in-India cervical cancer vaccine. This vaccine is formulated to target HPV types 16 and 18, as well as 6 and 11, strains that are responsible for at least 70% of cervical cancers. Its administration will be via injection, with two doses recommended for individuals aged 9–14-year-olds and three doses for those between 15 and 26.

Who Are The Companies Driving Activity In The Cancer Vaccines Market?

Major companies operating in the cancer vaccines market are GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen and Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., Ziopharm Oncology Inc.

Get The Full Cancer Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Which Region Leads The Cancer Vaccines Market In Terms Of Market Share?

North America was the largest region in the cancer vaccines market in 2025. The regions covered in the cancer vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cancer Vaccines Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Browse Through More Reports Similar to the Global Cancer Vaccines Market 2026, By The Business Research Company

Veterinary Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Therapeutic Proteins Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795